{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:39Z","timestamp":1792081539277,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0532204"],"award-info":[{"award-number":["2024ZD0532204"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2501700"],"award-info":[{"award-number":["2021YFC2501700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Independent Research Fund of the State Key Laboratory of Complex, Severe, and Rare Disease","award":["2025-I-PY-007"],"award-info":[{"award-number":["2025-I-PY-007"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-002"],"award-info":[{"award-number":["2021-I2M-1-002"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-D-006"],"award-info":[{"award-number":["2022-PUMCH-D-006"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82270938"],"award-info":[{"award-number":["No.82270938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81970757"],"award-info":[{"award-number":["No.81970757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2023-PT320-10"],"award-info":[{"award-number":["2023-PT320-10"]}]},{"name":"Beijing Natural Science Foundation","award":["7252109"],"award-info":[{"award-number":["7252109"]}]},{"name":"Peking Union Medical College Hospital Talent Cultivation Program Category D","award":["UHB11952"],"award-info":[{"award-number":["UHB11952"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-026-01722-9","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:23:11Z","timestamp":1782112991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness thresholds for initiating osteoporosis treatment in postmenopausal women in China: a microsimulation analysis based on real-world data"],"prefix":"10.1007","volume":"21","author":[{"given":"Lijia","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Jiajue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-5748","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"8","key":"1722_CR1","doi-asserted-by":"publisher","first-page":"e2121106","DOI":"10.1001\/jamanetworkopen.2021.21106","volume":"4","author":"L Wang","year":"2021","unstructured":"Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L et al (2021) Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open 4(8):e2121106","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1722_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-023-01353-4","volume":"19","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Zhang T, Shen Y, Shan PF (2023) The burden of fracture in China from 1990 to 2019. Arch Osteoporos 19(1):1","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1722_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11657-018-0549-y","volume":"14","author":"F Yu","year":"2019","unstructured":"Yu F, Xia W (2019) The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos 14(1):32","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1722_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58","journal-title":"Arch Osteoporos"},{"issue":"7","key":"1722_CR5","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1210\/jc.2008-0926","volume":"93","author":"B Dawson-Hughes","year":"2008","unstructured":"Dawson-Hughes B, National Osteoporosis Foundation Guide Committee (2008) A revised clinician\u2019s guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 93(7):2463\u20132465","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1722_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Od\u00e9n A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25","journal-title":"Arch Osteoporos"},{"issue":"3","key":"1722_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00198-011-1647-5","volume":"23","author":"EY Cheung","year":"2012","unstructured":"Cheung EY, Bow CH, Cheung CL et al (2012) Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women. Osteoporos Int 23(3):871\u2013878","journal-title":"Osteoporos Int"},{"issue":"2","key":"1722_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00198-019-05173-6","volume":"31","author":"L Cui","year":"2020","unstructured":"Cui L, He T, Jiang Y et al (2020) Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data. Osteoporos Int 31(2):307\u2013316","journal-title":"Osteoporos Int"},{"issue":"9","key":"1722_CR9","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00198-017-4085-1","volume":"28","author":"L Cui","year":"2017","unstructured":"Cui L, Chen L, Xia W et al (2017) Vertebral fracture in postmenopausal Chinese women: a population-based study. Osteoporos Int 28(9):2583\u20132590","journal-title":"Osteoporos Int"},{"issue":"3","key":"1722_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00198-011-1627-9","volume":"23","author":"CH Bow","year":"2012","unstructured":"Bow CH, Cheung E, Cheung CL et al (2012) Ethnic difference of clinical vertebral fracture risk. Osteoporos Int 23(3):879\u2013885","journal-title":"Osteoporos Int"},{"issue":"2","key":"1722_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00774-013-0484-3","volume":"32","author":"J Wang","year":"2014","unstructured":"Wang J, Wang Y, Liu WD, Wang F, Yin ZS (2014) Hip fractures in Hefei, China: the Hefei osteoporosis project. J Bone Miner Metab 32(2):206\u2013214","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"1722_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00198-007-0499-5","volume":"19","author":"CM Lofthus","year":"2008","unstructured":"Lofthus CM, Frihagen F, Meyer HE, Nordsletten L, Melhuus K, Falch JA (2008) Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int 19(6):781\u2013786","journal-title":"Osteoporos Int"},{"issue":"1","key":"1722_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1359\/jbmr.1997.12.1.16","volume":"12","author":"LJ Melton 3rd","year":"1997","unstructured":"Melton LJ 3rd, Thamer M, Ray NF et al (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12(1):16\u201323","journal-title":"J Bone Miner Res"},{"key":"1722_CR14","doi-asserted-by":"crossref","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott T 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721\u2013739","DOI":"10.1359\/jbmr.2000.15.4.721"},{"issue":"5","key":"1722_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513\u2013521","journal-title":"JAMA"},{"issue":"3","key":"1722_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11136-010-9762-x","volume":"20","author":"S Sun","year":"2011","unstructured":"Sun S, Chen J, Johannesson M et al (2011) Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res 20(3):309\u2013320","journal-title":"Qual Life Res"},{"issue":"8","key":"1722_CR17","first-page":"1987","volume":"25","author":"L Si","year":"2014","unstructured":"Si L, Winzenberg TM, de Graaff B, Palmer AJ (2014) A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporos Int 25(8):1987\u20131997","journal-title":"Osteoporos Int"},{"issue":"5","key":"1722_CR18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P, Kapoor E, Asi N et al (2019) Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104(5):1623\u20131630","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1722_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00198-020-05507-9","volume":"31","author":"G Koller","year":"2020","unstructured":"Koller G, Goetz V, Vandermeer B et al (2020) Persistence and adherence to parenteral osteoporosis therapies: a systematic review. Osteoporos Int 31(11):2093\u20132102","journal-title":"Osteoporos Int"},{"issue":"7","key":"1722_CR20","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00198-014-2699-0","volume":"25","author":"B Qu","year":"2014","unstructured":"Qu B, Ma Y, Yan M et al (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int 25(7):1853\u20131860","journal-title":"Osteoporos Int"},{"key":"1722_CR21","unstructured":"Pharmcube: Market drug price database of China. http:\/\/db. pharmcube.com\/database\/drugib\/index Accessed Jul.30 2025"},{"key":"1722_CR22","unstructured":"China Center for Health Economic Research (2020) China Guidelines for Pharmacoeconomic Evaluations 2020. Beijing"},{"key":"1722_CR23","unstructured":"China historical inflation rates. Available at: https:\/\/www.inflation.eu\/inflation-rates\/china\/historic-inflation\/cpi-inflation-china.aspx. Accessed 30 July 2025"},{"key":"1722_CR24","unstructured":"National Bureau of Statistics of China. 2020 China Population Census. Beijing: China Statistics Press; 2021. Available from: https:\/\/www.stats.gov.cn\/sj\/pcsj\/."},{"key":"1722_CR25","volume-title":"China guidelines for pharmacoeconomic evaluations 2020","author":"G Liu","year":"2020","unstructured":"Liu G (2020) China guidelines for pharmacoeconomic evaluations 2020. China Market, Beijing"},{"issue":"1","key":"1722_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-008-0644-9","volume":"20","author":"O Str\u00f6m","year":"2009","unstructured":"Str\u00f6m O, Borgstr\u00f6m F, Kanis JA, J\u00f6nsson B (2009) Incorporating adherence into health economic modelling of osteoporosis. Osteoporos Int 20(1):23\u201334","journal-title":"Osteoporos Int"},{"issue":"7","key":"1722_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.clinthera.2013.05.019","volume":"35","author":"TT Cheng","year":"2013","unstructured":"Cheng TT, Yu SF, Hsu CY, Chen SH, Su BY, Yang TS (2013) Differences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelines. Clin Ther 35(7):1005\u20131015","journal-title":"Clin Ther"},{"issue":"12","key":"1722_CR28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s40273-020-00954-y","volume":"38","author":"J Ochalek","year":"2020","unstructured":"Ochalek J, Wang H, Gu Y, Lomas J, Cutler H, Jin C (2020) Informing a cost-effectiveness threshold for health technology assessment in China: a marginal productivity approach. Pharmacoeconomics 38(12):1319\u20131331","journal-title":"Pharmacoeconomics"},{"key":"1722_CR29","unstructured":"State Administration of Foreign Exchange. Exchange rate: 1 CNY = 0.1399 USD. Available at: https:\/\/www.safe.gov.cn\/ Accessed 30 July 2025."},{"issue":"1","key":"1722_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F et al (2022) Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Value Health 25(1):3\u20139","journal-title":"Value Health"},{"key":"1722_CR31","unstructured":"National Health Commission of the People\u2019s Republic of China. China Health Statistics Yearbook 2024. Available at: http:\/\/www.nhc.gov.cn\/ Accessed 30 July 2025."},{"key":"1722_CR32","doi-asserted-by":"crossref","unstructured":"Tosteson AN, Melton L 3rd, Dawson-Hughes Bea et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437\u2013447","DOI":"10.1007\/s00198-007-0550-6"},{"issue":"10","key":"1722_CR33","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H et al (2008) Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395\u20131408","journal-title":"Osteoporos Int"},{"issue":"7","key":"1722_CR34","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00198-015-3055-8","volume":"26","author":"P Makras","year":"2015","unstructured":"Makras P, Athanasakis K, Boubouchairopoulou N et al (2015) Cost-effective osteoporosis treatment thresholds in Greece. Osteoporos Int 26(7):1949\u20131957","journal-title":"Osteoporos Int"},{"issue":"2","key":"1722_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00198-024-07328-6","volume":"36","author":"L Nagendra","year":"2025","unstructured":"Nagendra L, Chandran M, Reginster JY et al (2025) Cost-effectiveness of FRAX\u00ae-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis. Osteoporos Int 36(2):311\u2013322","journal-title":"Osteoporos Int"},{"issue":"1","key":"1722_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11657-016-0282-3","volume":"11","author":"\u00c9 Tremblay","year":"2016","unstructured":"Tremblay \u00c9, Perreault S, Dorais M (2016) Persistence with denosumab and zoledronic acid among older women: a population-based cohort study. Arch Osteoporos 11(1):30","journal-title":"Arch Osteoporos"},{"key":"1722_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2474-14-4","volume":"14","author":"L Hazel-Fernandez","year":"2013","unstructured":"Hazel-Fernandez L, Louder AM, Foster SA, Uribe CL, Burge RT (2013) Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study. BMC Musculoskelet Disord 14:4","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"1722_CR38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jval.2012.02.001","volume":"15","author":"M Hiligsmann","year":"2012","unstructured":"Hiligsmann M, McGowan B, Bennett K, Barry M, Reginster JY (2012) The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health 15(5):604\u2013612","journal-title":"Value Health"},{"issue":"3","key":"1722_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00198-010-1424-x","volume":"22","author":"B J\u00f6nsson","year":"2011","unstructured":"J\u00f6nsson B, Str\u00f6m O, Eisman JA et al (2011) Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int 22(3):967\u2013982","journal-title":"Osteoporos Int"},{"issue":"1","key":"1722_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2007.10.019","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Adams J, Borgstr\u00f6m F, Cooper C, J\u00f6nsson B, Preedy D, Selby P, Compston J (2008) The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42(1):4\u201315","journal-title":"Bone"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01722-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01722-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01722-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:23:30Z","timestamp":1782113010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01722-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01722-9","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder\/sponsor"}}],"article-number":"94"}}